NTRPNextTrip, Inc.

Nasdaq nexttrip.com


$ 1.50 $ -0.16 (-8.51 %)    

Friday, 14-Jun-2024 14:18:57 EDT
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 1.72
$ 1.73
$ 0.00 x 0
$ 0.00 x 0
$ 1.50 - $ 1.73
$ 1.48 - $ 9.40
11,634
na
963,733
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2023 09-30-2023 10-Q
2 08-14-2023 06-30-2023 10-Q
3 05-15-2023 03-31-2023 10-Q
4 03-30-2023 12-31-2022 10-K
5 11-14-2022 09-30-2022 10-Q
6 08-05-2022 06-30-2022 10-Q
7 04-26-2022 03-31-2022 10-Q
8 03-24-2022 12-31-2021 10-K
9 10-21-2021 09-30-2021 10-Q
10 07-22-2021 06-30-2021 10-Q
11 04-22-2021 03-31-2021 10-Q
12 03-24-2021 12-31-2020 10-K
13 10-22-2020 09-30-2020 10-Q
14 07-23-2020 06-30-2020 10-Q
15 05-14-2020 03-31-2020 10-Q
16 03-24-2020 12-31-2019 10-K
17 11-14-2019 09-30-2019 10-Q
18 08-14-2019 06-30-2019 10-Q
19 05-15-2019 03-31-2019 10-Q
20 04-01-2019 12-31-2018 10-K
21 11-14-2018 09-30-2018 10-Q
22 08-14-2018 06-30-2018 10-Q
23 05-15-2018 03-31-2018 10-Q
24 04-17-2018 12-31-2017 10-K
25 11-14-2017 09-30-2017 10-Q
26 08-14-2017 06-30-2017 10-Q
27 05-15-2017 03-31-2017 10-Q
28 03-31-2017 12-31-2016 10-K
29 11-14-2016 09-30-2016 10-Q
30 08-11-2016 06-30-2016 10-Q
31 05-12-2016 03-31-2016 10-Q
32 03-16-2016 12-31-2015 10-K
33 11-10-2015 09-30-2015 10-Q
34 08-07-2015 06-30-2015 10-Q
35 05-14-2015 03-31-2015 10-Q
36 03-31-2015 12-31-2014 10-K
37 11-14-2014 09-30-2014 10-Q
38 08-14-2014 06-30-2014 10-Q
39 05-15-2014 03-31-2014 10-Q
40 03-31-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 neurotrope-inc-board-approves-spin-off-of-neurotrope-bioscience-inc

Spin-Off Distribution is Conditional Upon the Closing of Neurotrope's Proposed Merger with Metuchen Pharmaceuticals NEW YO...

 insider-buys-neurotrope-stock
Insider Buys Neurotrope Stock
11/02/2020 15:00:15

  Neurotrope Inc (NASDAQ:NTRP) was trading 1.10% higher from the previous closing price. A Form 4 filing filed with the SEC on...

 insider-buys-neurotropes-stock
Insider Buys Neurotrope's Stock
10/26/2020 15:36:01

Neurotrope Inc (NASDAQ:NTRP) was trading 3.6% higher from the previous closing price. A Form 4 filing filed with the SEC on Mon...

 insider-buys-neurotrope-stock
Insider Buys Neurotrope Stock
10/22/2020 16:04:12

A Form 4 filing filed with the SEC on Thursday, October 22 showed that Schechter Jonathan bought 2,012 shares of Neurotrope Inc...

 insider-buys-neurotropes-stock
Insider Buys Neurotrope's Stock
10/20/2020 15:21:52

Neurotrope Inc (NASDAQ:NTRP) was trading 2.1% higher from the previous closing price. A Form 4 filing filed with the SEC on Tue...

 insider-buys-neurotropes-shares
Insider Buys Neurotrope's Shares
10/19/2020 15:43:57

Neurotrope Inc (NASDAQ:NTRP) was trading 4.6% higher from the previous closing price. Silverman Joshua filed a Form 4 with the ...

 neurotrope-reports-deal-with-worldwide-clinical-trials-to-conduct-ongoing-phase-2-study-of-bryostatin-1-for-alzheimers

Neurotrope, Inc. (NASDAQ:NTRP) ("Neurotrope" or the "Company") today announced that its wholly-owned subsidiary...

Core News & Articles

By Anita Dushyanth, PhD NASDAQ:INMB | NASDAQ:NTRP | TSX:PMN.TO Rethinking the approach to treat Alzheimer's disease